Karl-Erik Andersson (K-E Andersson)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Neurourology and urodynamics

Expert opinion on therapeutic targets

BJU international

International neurourology journal

Wake Forest University

Wake Forest University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wake Forest University Apr 01 2006

United States

Professor :: WFIRM

Education History

Wake Forest University Apr 01 2006

United States

PHD :: WFIRM

Publications

Karl-Erik Andersson
Promising therapeutic targets for the treatment of urine storage dysfunction: what's the status? Expert opinion on therapeutic targets 28 (4) (2024)
Karl-Erik Andersson
Promising therapeutic targets for the treatment of urine storage dysfunction: what's the status? Expert opinion on therapeutic targets 28 (4) (2024)
Karl-Erik Andersson
Promising therapeutic targets for the treatment of urine storage dysfunction: what's the status? Expert opinion on therapeutic targets (2024)
Bengt Uvelius, Rolf Lundgren, Karl-Erik Andersson
Gösta Jönsson (1909-1978): A pioneer in the hormonal treatment of prostate cancer in Sweden. Journal of medical biography (2024)
Karl-Erik Andersson
Promising therapeutic targets for the treatment of urine storage dysfunction: what's the status? Expert opinion on therapeutic targets (2024)
Karl-Erik Andersson, Koudy Williams
Cellular regenerative therapy in stress urinary incontinence: new frontiers?-a narrative review. Translational andrology and urology 13 (8) (2023)
Bengt Uvelius, Karl-Erik Andersson
Molecular and Morphological Characteristics of the De-Obstructed Rat Urinary Bladder-An Update. International journal of molecular sciences 23 (19) (2022)
Karl-Erik Andersson, Delphine Behr-Roussel, Pierre Denys, Francois Giuliano
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation. Medical sciences (Basel, Switzerland) 10 (3) (2022)
Irina V Zabbarova, Youko Ikeda, Mark G Kozlowski, Pradeep Tyagi, Lori Ann Birder, Basu Chakrabarty, Subashan Kpg Perera, Rajiv Dhir, Adam C Straub, Peter Sandner, Karl-Erik Andersson, Marcus J Drake, Christopher Henry Fry, Anthony J Kanai
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. The Journal of pathology 256 (4) (2022)
Florian Alexander Schmid, J Koudy Williams, Thomas M M Kessler, Arnulf Stenzl, Wilhelm K Aicher, Karl-Erik Andersson, Daniel Eberli
Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects. International journal of molecular sciences 22 (8) (2021)
Matthew O Fraser, Phillip P Smith, Maryrose P Sullivan, Dale E Bjorling, Lysanne Campeau, Karl-Erik Andersson, Mitsuharu Yoshiyama
Best practices for cystometric evaluation of lower urinary tract function in muriform rodents. Neurourology and urodynamics 39 (6) (2020)
Karl-Erik Andersson, Lori Ann Birder, Christopher J Chermansky, Russell Chess-Williams, Christopher Henry Fry
Are there relevant animal models to set research priorities in LUTD? ICI-RS 2019. Neurourology and urodynamics (2020)
John E Speich, Tufan Tarcan, Hikaru Hashitani, Bahareh Vahabi, Karen D McCloskey, Karl-Erik Andersson, Alan J Wein, Lori Ann Birder
Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI-RS 2019. Neurourology and urodynamics (2020)
Karl-Erik Andersson
Oxidative stress and lower urinary tract symptoms: cause or consequence? BJU international 123 (5) (2019)
Karl-Erik Andersson
TRP Channels as Lower Urinary Tract Sensory Targets. Medical sciences (Basel, Switzerland) 7 (5) (2019)
Christopher Henry Fry, Basu Chakrabarty, Hikaru Hashitani, Karl-Erik Andersson, Karen D McCloskey, Rita I Jabr, Marcus J Drake
New targets for overactive bladder-ICI-RS 2109. Neurourology and urodynamics (2019)
Karl-Erik Andersson, Christopher Fry, Jalesh Panicker, Kevin Rademakers
Which molecular targets do we need to focus on to improve lower urinary tract dysfunction? ICI-RS 2017. Neurourology and urodynamics 37 (S4) (2019)
Marc Colaco, Nadir I Osman, Ahmet Karakeçi, Walter Artibani, Karl-Erik Andersson, Gopal H Badlani
Current concepts of the acontractile bladder. BJU international 122 (2) (2018)
Karl-Erik Andersson
PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. British journal of pharmacology 175 (13) (2018)
Lori Ann Birder, Karl-Erik Andersson
Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome. International neurourology journal 22 (Suppl 1) (2018)
Karl-Erik Andersson
Oxidative stress and its possible relation to lower urinary tract functional pathology. BJU international 121 (4) (2017)
Karl-Erik Andersson, Lori Ann Birder
Current Pharmacologic Approaches in Painful Bladder Research: An Update. International neurourology journal 21 (4) (2017)
Marc Possover, Karl-Erik Andersson, Axel Forman
Neuropelveology: An Emerging Discipline for the Management of Chronic Pelvic Pain. International neurourology journal 21 (4) (2017)

Karl-Erik Andersson.css-eqlu8i{font-size:small;padding-left:4px;} (K-E Andersson)

Publication Activity (10 Years)

Top Topics

Top Venues

Karl-Erik Andersson (K-E Andersson)